Evidence map›Paper›PMID 26991680›Full record

ArticleMagnetic resonance in medicine2017

In vivo detection of 2-hydroxyglutarate in brain tumors by optimized point-resolved spectroscopy (PRESS) at 7T.

Sandeep K Ganji, Zhongxu An, Vivek Tiwari, Sarah McNeil, Marco C Pinho, Edward Pan, Bruce E Mickey, Elizabeth A Maher, Changho Choi

Abstract readEvaluation Study
In one paragraph

Article in Magnetic resonance in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical application ofFrontiers in neuroscience · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Glutamine Imaging: A New Avenue for Glioma Management.AJNR. American journal of neuroradiology · 2022
    Review
  12. Article
  13. Spectral editing inNMR in biomedicine · 2021
    Article
  14. Magnetic resonance spectroscopy for the study of cns malignancies.Progress in nuclear magnetic resonance spectroscopy · 2021
    Article
  15. Article
  16. Article
  17. An integrated RF-receive/BScientific reports · 2020
    Article
  18. Article
  19. In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sandeep K GanjiAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Zhongxu AnAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vivek TiwariAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Sarah McNeilHarold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Marco C PinhoAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Edward PanHarold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Bruce E MickeyHarold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Elizabeth A MaherHarold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Changho ChoiAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · USAdvanced Imaging Research (United States) · USNeurological Surgery · US

Funding

Clinical development of cancer-specific MRS biomarkers in malignant gliomasR01CA184584 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHOI, CHANGHO · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA184584
6 · The paper itself

Abstract

purposeTo test the efficacy of 7T MRS for in vivo detection of 2-hydroxyglutarate (2HG) in brain tumors.

methodsThe subecho times of point-resolved spectroscopy (PRESS) were optimized at 7T with density-matrix simulations and phantom validation to improve the 2HG signal selectivity with respect to the neighboring resonances of γ-aminobutyric acid (GABA), glutamate (Glu), and glutamine (Gln). MRS data were acquired from 12 subjects with gliomas in vivo and analyzed with LCModel using calculated basis spectra. Metabolite levels were quantified using unsuppressed short echo time (TE) water as a reference.

resultsThe PRESS TE was optimized as TE = 78 ms (TE

conclusionData indicate that the optimized MRS provides good selectivity of 2HG from other metabolite signals and may confer reliable in vivo detection of 2HG at relatively low concentrations. Magn Reson Med 77:936-944, 2017. © 2016 International Society for Magnetic Resonance in Medicine.

Indexed as

AlgorithmsSignal Processing, Computer-AssistedBiomarkers, TumorBrainBrain NeoplasmsGlutaratesHumansMagnetic Resonance SpectroscopyReproducibility of ResultsSensitivity and Specificityalpha-hydroxyglutarateBiomarkers, TumorGlutarates1H MRS2-hydroxyglutarate (2HG)7T, PRESS (point-resolved spectroscopy)gliomashuman brain tumorsIDH (isocitrate dehydrogenase)

Identifiers

PMID26991680
PMCPMC5026542
OpenAlexW2301401527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.